PM
58
2
ABT
57
-5
GPC
40
2
TRV
56
-2
BK
72
-2
COF
63
-4
DFS
67
-3
SRE
66
-3
DLTR
40
4
AMAT
43
-5
FLR
48
3
RSG
77
4
NOV
58
-2
DG
12
2
AAPL
45
3
FTI
78
-3
DRI
56
2
IFF
53
2
MAT
38
-3
UA
57
4
PM
58
2
ABT
57
-5
GPC
40
2
TRV
56
-2
BK
72
-2
COF
63
-4
DFS
67
-3
SRE
66
-3
DLTR
40
4
AMAT
43
-5
FLR
48
3
RSG
77
4
NOV
58
-2
DG
12
2
AAPL
45
3
FTI
78
-3
DRI
56
2
IFF
53
2
MAT
38
-3
UA
57
4
Financhill
Back

FibroGen Vs. Arbutus Biopharma Industry Stock Comparison

Sell
47

FGEN
FibroGen

Last Price:
0.37
Seasonality Move:
40.41%
Sell
41

ABUS
Arbutus Biopharma

Last Price:
3.63
Seasonality Move:
13.65%
Sell
47
FibroGen (FGEN) is a Sell

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.33. The Score for FGEN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.65. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.33
    The current trend is relatively stagnant and FGEN is experiencing slight buying pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.45 Sell
Chaikin Money Flow: 905454 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.3 - 0.36) Buy
Bollinger Bands (100): (0.25 - 0.85) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 36.73 Sell
Chaikin Money Flow: -592634 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.77 - 4.07) Sell
Bollinger Bands (100): (3.49 - 4.15) Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.33 Buy
20-day SMA: 0.33 Buy
50-day SMA: 0.37 Sell
200-day SMA: 1.08 Sell
8-day EMA: 0.33 Sell
20-day EMA: 0.33 Sell
50-day EMA: 0.39 Sell
200-day EMA: 1.28 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.78 Sell
20-day SMA: 3.93 Sell
50-day SMA: 4.02 Sell
200-day SMA: 3.34 Buy
8-day EMA: 3.76 Sell
20-day EMA: 3.86 Sell
50-day EMA: 3.89 Sell
200-day EMA: 3.42 Buy

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):